Karachaliou, Niki <br/><br/>
Predictive value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC genes in patients with small cell lung cancer (SCLC) who received first line therapy with cisplatin and etoposide.  [electronic resource] 

 -  PloS one  2013 
 - e74611 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0074611  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine Triphosphatases--genetics<br/>Adult<br/>Aged<br/>Antigens, Neoplasm--genetics<br/>BRCA1 Protein--genetics<br/>Carrier Proteins--genetics<br/>Cation Transport Proteins--genetics<br/>Cisplatin--pharmacology<br/>Copper-Transporting ATPases<br/>DNA Topoisomerases, Type I--genetics<br/>DNA Topoisomerases, Type II--genetics<br/>DNA-Binding Proteins--genetics<br/>Disease-Free Survival<br/>Endonucleases--genetics<br/>Etoposide--pharmacology<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Genes, Neoplasm--genetics<br/>Genes, myc<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Membrane Proteins--genetics<br/>Middle Aged<br/>Multivariate Analysis<br/>Predictive Value of Tests<br/>RNA, Messenger--genetics<br/>Small Cell Lung Carcinoma--drug therapy<br/>Thyroid Hormones--genetics<br/>Treatment Outcome<br/>Thyroid Hormone-Binding Proteins